These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16890891)

  • 1. Urinary biomarkers in lupus nephritis.
    Li Y; Tucci M; Narain S; Barnes EV; Sobel ES; Segal MS; Richards HB
    Autoimmun Rev; 2006 Jul; 5(6):383-8. PubMed ID: 16890891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis.
    Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC
    Nephrol Dial Transplant; 2006 Jun; 21(6):1534-40. PubMed ID: 16449281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.
    Kiani AN; Johnson K; Chen C; Diehl E; Hu H; Vasudevan G; Singh S; Magder LS; Knechtle SJ; Petri M
    J Rheumatol; 2009 Oct; 36(10):2224-30. PubMed ID: 19648301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
    Alzawawy A; Zohary M; Ablordiny M; Eldalie M
    Int J Rheum Dis; 2009 Dec; 12(4):311-8. PubMed ID: 20374368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine chemokines as biomarkers of human systemic lupus erythematosus activity.
    Rovin BH; Song H; Birmingham DJ; Hebert LA; Yu CY; Nagaraja HN
    J Am Soc Nephrol; 2005 Feb; 16(2):467-73. PubMed ID: 15601744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary TWEAK and the activity of lupus nephritis.
    Schwartz N; Su L; Burkly LC; Mackay M; Aranow C; Kollaros M; Michaelson JS; Rovin B; Putterman C
    J Autoimmun; 2006 Dec; 27(4):242-50. PubMed ID: 17257812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis.
    Noris M; Bernasconi S; Casiraghi F; Sozzani S; Gotti E; Remuzzi G; Mantovani A
    Lab Invest; 1995 Dec; 73(6):804-9. PubMed ID: 8558841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
    Abujam B; Cheekatla S; Aggarwal A
    Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary levels of IL-6 in patients with active lupus nephritis.
    Iwano M; Dohi K; Hirata E; Kurumatani N; Horii Y; Shiiki H; Fukatsu A; Matsuda T; Hirano T; Kishimoto T
    Clin Nephrol; 1993 Jul; 40(1):16-21. PubMed ID: 8358870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
    Chan RW; Lai FM; Li EK; Tam LS; Wong TY; Szeto CY; Li PK; Szeto CC
    Arthritis Rheum; 2004 Sep; 50(9):2882-90. PubMed ID: 15457456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients.
    Rosa RF; Takei K; Araújo NC; Loduca SM; Szajubok JC; Chahade WH
    J Rheumatol; 2012 Oct; 39(10):1948-54. PubMed ID: 22942263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
    Tam FW; Sanders JS; George A; Hammad T; Miller C; Dougan T; Cook HT; Kallenberg CG; Gaskin G; Levy JB; Pusey CD
    Nephrol Dial Transplant; 2004 Nov; 19(11):2761-8. PubMed ID: 15353578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response.
    Wang G; Lai FM; Tam LS; Li EK; Kwan BC; Chow KM; Li PK; Szeto CC
    Rheumatology (Oxford); 2009 Jul; 48(7):755-60. PubMed ID: 19458162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis.
    Tucci M; Calvani N; Richards HB; Quatraro C; Silvestris F
    Ann N Y Acad Sci; 2005 Jun; 1051():421-32. PubMed ID: 16126984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker discovery in human SLE nephritis.
    Rovin BH; Birmingham DJ; Nagaraja HN; Yu CY; Hebert LA
    Bull NYU Hosp Jt Dis; 2007; 65(3):187-93. PubMed ID: 17922668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
    Stangou M; Alexopoulos E; Papagianni A; Pantzaki A; Bantis C; Dovas S; Economidou D; Leontsini M; Memmos D
    Nephrology (Carlton); 2009 Sep; 14(6):613-20. PubMed ID: 19143943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis.
    Marks SD; Williams SJ; Tullus K; Sebire NJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3521-6. PubMed ID: 18495743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus nephritis biomarkers.
    Soliman S; Mohan C
    Clin Immunol; 2017 Dec; 185():10-20. PubMed ID: 27498110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary fibronectin as an indicator of kidney fibrosis in nephritis].
    Kozlovskaia LV; Bobkova IN; Varshavskiĭ VA; Proskurneva EP; Miroshnichenko NG; Chebotareva NV; Mukhin NA
    Ter Arkh; 1999; 71(6):34-8. PubMed ID: 10420453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis.
    Nozaki Y; Kinoshita K; Yano T; Shiga T; Hino S; Niki K; Kishimoto K; Funauchi M; Matsumura I
    Lupus; 2014 Jul; 23(8):769-77. PubMed ID: 24598218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.